Quantum BioPharma Ltd.
QNTM
$3.24
-$0.20-5.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.88% | -49.26% | -84.30% | -178.49% | -261.70% |
| Total Depreciation and Amortization | 5.11% | 8.68% | 11.27% | 5.86% | -4.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.34% | 4,220.93% | 627.47% | 4,137.57% | 580.99% |
| Change in Net Operating Assets | -43.85% | -115.09% | -79.65% | 180.31% | 97.94% |
| Cash from Operations | 47.79% | 38.40% | -19.78% | -27.20% | -104.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.05% | -23.45% | -29.86% | 61.45% | -1,289.08% |
| Cash from Investing | 29.05% | -23.45% | -29.86% | 61.45% | -1,204.39% |
| Total Debt Issued | -47.85% | 29.80% | 429.40% | -- | 1,809.78% |
| Total Debt Repaid | -106.71% | -3,509.82% | -2,429.83% | -1,390.54% | -701.46% |
| Issuance of Common Stock | -5.83% | -43.58% | -95.04% | -81.74% | 307.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.31% | -29.75% | -47.51% | -21.63% | 484.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.82% | -62.35% | -226.30% | -420.60% | 23.48% |